Welcome to our Liver Cancer Connect Program
Find Clinical Trials Near Me!
Check out this video with a liver cancer survivor on Closing the Care Gap!
This panel discussion features someone with lived experience of liver cancer and his wife in conversation with researchers and patient advocates. The discussion highlights what is missing in order to improve the lives of people diagnosed with HCC. Check it out today!
Watch our latest webinar! In it, panelists discuss conclusions & insights from a recent project to identify & close disparities in hepatitis B & liver cancer knowledge and screening rates among highly impacted communities around the US. Check it out today!
Check out a special episode from the 2022 HBV Meeting in Paris! Ed Tate, Director of Communications and Marketing at the Hepatitis B Foundation was able to interview Dr. Mathias Heikenwalder to talk about updates on liver cancer research.
Liver Cancer Connect is a dedicated program of the Hepatitis B Foundation that was created to provide individuals and families with the information and support they need when facing the challenge of primary liver cancer. Although this is a serious diagnosis, there is good reason to have hope because of the many advances made in the early detection, management and treatment of liver cancer.
In the News
Advancing the Care of Advanced HCC – A Hepatologist’s Perspective
After FDA rejection, Gilead's Hepcludex looks set for full EU nod
Evidence Grows for Avoiding Biopsy in Hepatocellular Carcinoma
Novel Use of Artificial Intelligence Shows Promise to Improve HCC Detection
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
Generic Drugs in Oncology (Recent Lancet article)
4 Liver Cancer Treatment Advances
The Cancer Experience Registry is an online survey that allows people facing cancer to share their experiences, identify the issues that impact their life, and help them understand their experiences.
Review of insights into the success and failure of systemic therapy for liver cancer
REACH-B Score for Hepatocellular Carcinoma
About Herbs, Botanicals, and Other Products (from Memorial Sloan Kettering Cancer Center)
Case 3: Novel Frontline Combination Strategies for Unresectable HCC (Video)
Assessing the Risk of HCC for Hepatitis B Treatments
Study Uncovers New Treatment Approaches for Liver Cancer Patients
NUS Scientists Discover New Clues to Liver Cancer Progression
What Gastroenterologists Need to Know About New Guidelines on Systemic HCC Therapy
Bringing Early Cancer Detection to the Masses
Researchers Identify a New tsRNA in Blood to Improve Liver Cancer Diagnosis
New strategies and the partnerships needed to bring early detection of cancer to everyone
NCCN Guidelines for Patients Liver Cancer
Immunotherapy for advanced HCC: Experts answer clinician questions
Current and Future Immunotherapy Approaches for HCC: Evidence, Guidance, and Resources (Podcast)
Insights into the success and failure of systemic therapy for hepatocellular carcinoma
What Cancer Survivors Should Know About Their Mental Health
EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma